$MO

UBS raises Altria stock price target to $83 on strong quarter

UBS raised its price target on Altria Group (NYSE:MO) to $83, citing strong Q3 2026 revenue growth of 3.6% and raised EPS guidance. The stock trades near its 52-week high, up 43% over the past year. Altria's dividend yield is 5.79%, and it has raised dividends for 16 consecutive years. Recent earnings beat estimates, with EPS of $1.52 and revenue of $6.13 billion. Goldman Sachs and BofA Securities also raised their price targets.

Original reporting
Published Oct 30, 2026, 3:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 3:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MO
Bullish
high confidence
Mentioned
$MO
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$MOBullishHigh
01

Why it matters

Analyst price target hikes signal near‑term upside potential for the stock.

02

Market read

Earnings beat and upgraded guidance drive bullish sentiment for MO.

03

What to watch

Possible future regulatory constraints on cigarette volumes could limit long‑term growth.

Relevance 8/10Novelty 8/10Timing: after earnings release today

Background

Altria reported Q3 2026 earnings that beat expectations, prompting multiple analyst upgrades.

Company-level read

Ticker impact

$MOBullishHigh confidence
Context

UBS and other banks raised price targets on Altria (MO) after its Q3 2026 earnings beat and raised guidance.

Expected impact

likely upward pressure as the market prices in higher targets and improved guidance

Evidence & confidence

Earnings beat, revenue beat, and raised guidance drive analysts to lift price targets, indicating bullish sentiment.

Market effects

Strong performance may lift other tobacco and consumer staples stocks.

U.S. market may see modest gains in dividend‑focused sectors.

Limited to U.S. equities; no broader macro impact.

Counterpoint

High dividend yield may attract income investors despite potential regulatory headwinds.

Key entities

  • Altria Group Inc.

    Tobacco and nicotine products company.

  • UBS

    Raised price target to $83.

Related articles

$MOHighAI 8/10

America’s Greatest Dividend Posts Strong Earnings

Altria (MO) reported Q3 revenue of $6.1B (+1% YoY) and EPS of $1.51 (+7% YoY), beating expectations. The company raised its full-year earnings guidance, citing strong performance. Shares rose 6% over two days and are up 33% YTD. CEO Sal Mancuso highlighted confidence in the full-year plan. Marlboro, with a 40% U.S. market share, drives most revenue. Other high-yield companies like UPS, Kraft Heinz, and General Mills face economic sensitivity and competition.

$MOMed

Goldman Sees More Upside in Altria After Strong Quarter

Goldman Sachs raised its price target for Altria (MO) to $83 from $77, citing better-than-expected Q3 earnings and revenue. Adjusted EPS was $1.52, beating estimates, and revenue reached $6.13B. Management increased its 2026 EPS growth outlook. Goldman expects continued benefits from tax drawbacks and a manufacturing agreement with Philip Morris. MO stock is up 40% year-to-date.

$MOHighAI 8/10

What Just Happened To Altria Stock?

Altria (MO) shares rose 5.2% on October 29, 2026, after beating Q3 earnings estimates and raising its full-year guidance. The company reported adjusted earnings of $1.52 per share on $5.44 billion in revenue, exceeding forecasts. Management raised its 2026 earnings outlook to $5.66-$5.74 per share, up from prior guidance. The stock closed at $76.75, its highest in a year, with a 29.5% return over the past 12 months.

$MOMedAI 8/10

What Altria Group (MO) Said on Its Q3 Earnings Call

Altria (MO) reported Q3 pricing realization of 4.4%, with Marlboro's premium segment share rising to 60%. Discount segment grew to 34.1%, and nicotine pouch category expanded. Helix's on! shipment volume increased 13.3%. Altria returned $6B to shareholders and raised its dividend. The company also discussed regulatory actions and plans to re-enter the e-vapor market.

$MOHighAI 8/10

Goldman Sachs raises Altria stock price target on earnings beat

Goldman Sachs increased its price target for Altria (MO) to $83 from $77, citing better-than-expected Q3 earnings of $1.52 per share. The firm noted strong equity income growth and raised fiscal 2026 EPS growth guidance to 4.5%-6.0%. Altria's Q3 revenue reached $6.13B, exceeding estimates of $5.31B, and the stock has surged nearly 40% year-to-date.

$MOMedAI 8/10

Altria Group, Inc. Q3 2026 Earnings Call Summary

Altria Group reported Q3 2026 earnings, highlighting smokeable segment growth driven by Marlboro Cowboy Cut and Basic brands. Helix's on! brand saw 13.3% shipment volume growth. The company raised full-year adjusted EPS guidance to $5.66-$5.74. Altria plans a disciplined re-entry into the e-vapor market with NJOY ACE and expanded its share repurchase program by $1 billion. Management emphasized resilience in cigarette volumes and long-term growth strategies.